Keith Katkin Insider Trading $UROV Urovant Sciences Ltd.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith Katkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith Katkin. Keith Katkin is Sr. V.P. of Sales & Marketing in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Carbylan Therapeutics, Inc. ($CBYL) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in Novus Therapeutics, Inc. ($NVUS) and PEO;CEO-Urovant Sciences,Inc. in Urovant Sciences Ltd. ($UROV) and PEO;CEO/Urovant Sciences, Inc. in Urovant Sciences Ltd. ($UROV).
Keith Katkin in Urovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin: PEO;CEO/Urovant Sciences, Inc., PEO;CEO-Urovant Sciences,Inc.
Holdings: 379,680 shares
Latest Transaction: Feb 21 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Keith Katkin in Urovant Sciences Ltd.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVNR, ELDN, KALV, RIGL, SNDX, UROV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Option Exercise | M | 3.86 | 180,000 | 694,800 | 701,254 | |
| Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Sell | J | 13.08 | 75,212 | 983,773 | 199,680 | 274.9 K to 199.7 K (-27.36 %) |
| Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Payment of Exercise | F | 13.08 | 104,788 | 1,370,627 | 274,892 | 379.7 K to 274.9 K (-27.60 %) |
| Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Buy | M | 3.86 | 180,000 | 694,800 | 379,680 | 199.7 K to 379.7 K (+90.14 %) |
| Jan 09 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Grant | A | 0.00 | 199,680 | 0 | 199,680 | 0 to 199.7 K |
| Dec 11 2019 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Option Exercise | M | 3.86 | 120,000 | 463,200 | 881,254 | |
| Dec 11 2019 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Sell | S | 12.78 | 120,000 | 1,533,600 | 0 | 120 K to 0 (-100.00 %) |
| Dec 11 2019 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Buy | M | 3.86 | 120,000 | 463,200 | 120,000 | 0 to 120 K |
| Jan 08 2019 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Option Exercise | A | 6.88 | 350,250 | 2,409,720 | 350,250 | |
| Oct 17 2018 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO-Urovant Sci ... | Option Exercise | A | 13.65 | 99,967 | 1,364,550 | 99,967 | |
| Oct 03 2018 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO-Urovant Sci ... | Option Exercise | A | 3.86 | 200,250 | 772,965 | 200,250 | |
| Sep 28 2018 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO-Urovant Sci ... | Option Exercise | A | 14.00 | 39,815 | 557,410 | 39,815 |
Page: 1